Jeffrey T. Weideman
Physician Assistant in Mankato, MN
About Jeffrey Weideman
Jeffrey Weideman is a physician assistant practicing in Mankato, MN. Records list 3 practice addresses. Treated 383 Medicare patients in 2024.
| Specialty | Physician AssistantOther physician assistants in Mankato |
|---|---|
| Gender | Male |
| NPI number | 1013149079National Provider Identifier (CMS NPPES), issued August 2009 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
Where Jeffrey Weideman practices
- Mankato Clinic Ltd 1230 E Main St, Mankato, MN 56001 Directions · group of 244 clinicians
- Mankato Clinic Ltd 1575 Lookout Dr, North Mankato, MN 56003 (507) 625-5027 · Directions · group of 244 clinicians
- Mankato Clinic Ltd 1901 Old Minnesota Ave, Saint Peter, MN 56082 Directions · group of 244 clinicians
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Jeffrey Weideman's specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Physician Assistant Primary | MN 10628 |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Jeffrey Weideman's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 962 | $5.67 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 313 | $74.62 |
| Destruction of precancer skin growth, 1 growth | 238 | $44.20 |
| Biopsy of related skin growth, first growth | 128 | $78.37 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 111 | $105.59 |
| Destruction of skin growth, 1-14 growths | 90 | $94.14 |
| Biopsy of related skin growth, each additional growth | 61 | $41.87 |
| Destruction of precancer skin growth, 15 or more growths | 33 | $139.45 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Payments from drug and device companies to Jeffrey Weideman (2025)
$298.64 in 7 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 7 | $298.64 |
Paying companies: Incyte Corporation ($155.68), LEO Pharma Inc. ($46.47), UCB, Inc. ($24.94), Amgen Inc. ($21.44), Arcutis Biotherapeutics, Inc. ($19.13), Regeneron Healthcare Solutions, Inc. ($15.88).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Jeffrey Weideman
What kind of clinician is Jeffrey Weideman?
Jeffrey Weideman is listed as a physician assistant.
Where does Jeffrey Weideman practice?
Mankato Clinic Ltd at 1230 E Main St, Mankato, MN 56001, and 2 other addresses in the records.
What is the office phone number for Jeffrey Weideman?
The listed office number is (507) 625-5027. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Jeffrey Weideman?
The National Provider Identifier is 1013149079.
Does Jeffrey Weideman accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2026-10-27 |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.